Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Guanylyl cyclase C receptor (GC-C), also known as guanylate cyclase 2C, is a membrane-bound receptor predominantly expressed on the apical surface of intestinal epithelial cells. It functions as a key regulator of fluid and electrolyte homeostasis in the gastrointestinal tract and is targeted pharmacologically by peptide agonists such as linaclotide and plecanatide for treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS‑C). Its expression pattern also makes it a promising biomarker for colorectal cancer detection.
Upon ligand binding, GC-C catalyzes the conversion of GTP to cGMP inside target cells, increasing intracellular cGMP, which modulates several downstream pathways that regulate intestinal fluid secretion and electrolyte transport.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Guanylyl Cyclase C Receptor (GC-C).